Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.

Talcott JA, Rossi C, Shipley WU, Clark JA, Slater JD, Niemierko A, Zietman AL.

JAMA. 2010 Mar 17;303(11):1046-53. doi: 10.1001/jama.2010.287. Erratum in: JAMA. 2010 Apr 7;303(13):1257.

PMID:
20233822
2.

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU.

JAMA. 2005 Sep 14;294(10):1233-9. Erratum in: JAMA. 2008 Feb 27;299(8):899-900.

PMID:
16160131
3.

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.

Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):415-9.

PMID:
15667961
4.
5.
6.
7.

Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.

Yeoh EE, Fraser RJ, McGowan RE, Botten RJ, Di Matteo AC, Roos DE, Penniment MG, Borg MF.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):943-55.

PMID:
12605972
8.

Dose response in prostate cancer with 8-12 years' follow-up.

Hanks GE, Hanlon AL, Epstein B, Horwitz EM.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):427-35.

PMID:
12243818
9.

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.

Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ, et al.

Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):3-12.

PMID:
7721636
10.

Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.

Coen JJ, Paly JJ, Niemierko A, Weyman E, Rodrigues A, Shipley WU, Zietman AL, Talcott JA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e201-9. doi: 10.1016/j.ijrobp.2011.03.048. Epub 2011 May 27.

PMID:
21621343
12.

Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.

Pinkawa M, Piroth MD, Fischedick K, Holy R, Klotz J, Nussen S, Krenkel B, Eble MJ.

Strahlenther Onkol. 2009 Nov;185(11):724-30. doi: 10.1007/s00066-009-2008-6. Epub 2009 Nov 10.

PMID:
19899005
13.

Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?

Seo PH, D'Amico AV, Clark JA, Kaplan I, Manola JB, Mitchell SP, Talcott JA.

Clin Prostate Cancer. 2004 Jun;3(1):38-42.

PMID:
15279689
14.

[Options of hypofractionation of proton boost in locally advanced prostate cancer].

KhmelevskiÄ­ EV, Pan'shin GA, Kancheli IN, Khoroshkov VS.

Vopr Onkol. 2012;58(6):787-94. Russian.

PMID:
23600305
15.

Stereotactic body radiotherapy for organ-confined prostate cancer.

Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M.

BMC Urol. 2010 Feb 1;10:1. doi: 10.1186/1471-2490-10-1.

17.

Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer.

Kupelian PA, Mohan DS, Lyons J, Klein EA, Reddy CA.

Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):567-74.

PMID:
10701735
18.

Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.

Chen RC, Zhang Y, Chen MH, McMahon E, Loffredo M, McPherson CP, Nguyen AU, Nguyen PL, D'Amico AV.

BJU Int. 2012 Dec;110(11):1690-5. doi: 10.1111/j.1464-410X.2012.11117.x. Epub 2012 Apr 13.

19.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.

J Urol. 2001 Sep;166(3):876-81. Erratum in: J Urol 2001 Nov;166(5):1839.

PMID:
11490237
20.

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.

Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.

Supplemental Content

Support Center